USE OF MODERN SCORES TO EVALUATE INDIVIDUAL RISK/BENEFIT OF PROLONGED DUAL ANTIPLATELET THERAPY MAY MODIFY DUAL ANTI-PLATELET THERAPY DURATION IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS
2017 ◽
Vol 69
(11)
◽
pp. 1021
2018 ◽
Vol 10
(1)
◽
pp. 6-7
2013 ◽
Vol 166
(5)
◽
pp. 864-870
◽
2014 ◽
Vol 2
(1)
◽
pp. 76-89
◽
2018 ◽
Vol 11
(9)
◽
2011 ◽
Vol 108
(12)
◽
pp. 1704-1709
◽